The stock is in a sustained uptrend, having gained 32.17% over the past year, significantly outperforming the broader market's 29.8% return. As of the latest data, the price of $202.33 positions it at approximately 93% of its 52-week high of $216.43, indicating the stock is trading near its recent peak and reflects strong investor momentum, though it also suggests potential vulnerability to profit-taking or overextension. The 1-month price change of -2.73% contrasts with the positive 1-year trend, signaling a recent short-term pullback or consolidation after the strong run, a divergence that may represent a healthy pause rather than a reversal, especially given the stock's positive relative strength of 1.01 against the S&P 500 over the same period.

Recent momentum shows a deceleration from the medium-term trend, with the 3-month return at 8.23% compared to the 1-year gain of 32.17%. The 1-month decline of -2.73% occurred while the S&P 500 fell -3.74%, indicating the stock demonstrated relative resilience (RSI data not available). This short-term weakness likely represents a consolidation phase following the sharp rally from the February 2026 high of $215.48, as the market digests gains and awaits new catalysts, such as further clarity on interest rates.

Key technical support is anchored at the 52-week low of $130.29, with immediate support likely forming around the recent March 2026 low near $195. Resistance is clearly defined at the 52-week high of $216.43. A decisive breakout above this level would signal a resumption of the primary uptrend and could target new highs, while a breakdown below the $195 support area might indicate a deeper correction is underway. With a beta of 0.82, Welltower exhibits lower volatility than the broader market, which is typical for a large-cap REIT, suggesting its price movements, while significant, are generally less dramatic than the overall equity market, a factor for risk-adjusted portfolio construction.

Revenue growth is robust and accelerating, with Q4 2025 revenue reaching $3.13 billion, representing a substantial 41.2% year-over-year increase. This growth is part of a clear multi-quarter uptrend, as quarterly revenue has climbed sequentially from $2.39 billion in Q1 2025 to the current $3.13 billion. The primary driver appears to be the company's core property operations, though specific segment data is limited to a 'Management Service' line of $2.06 billion; the strong overall growth trajectory underscores recovering fundamentals in the healthcare real estate sector, particularly in senior housing occupancy and rental rates.

Profitability is positive but showed significant quarter-to-quarter volatility in 2025. Q4 2025 net income was $96.4 million, yielding a net margin of 3.1%, which is a sharp decline from the Q3 2025 net income of $280.6 million and net margin of 10.7%. Gross margin for Q4 2025 was 38.3%, slightly down from 39.9% in Q3. This compression in Q4, where EBITDA was negative -$459 million compared to positive $979 million in Q3, suggests the quarter included significant one-time or non-cash charges (potentially impairments or revaluations), making the underlying operating profit trend more stable than the bottom-line figures imply.

The balance sheet and cash flow position is strong. The company maintains a healthy current ratio of 5.34 and a conservative debt-to-equity ratio of 0.51, indicating ample liquidity and a manageable leverage profile for a REIT. Most notably, trailing twelve-month free cash flow is a robust $2.85 billion. This substantial FCF generation, coupled with an ROE of 2.22%, demonstrates the company's ability to fund operations and growth internally, reducing reliance on external capital markets—a critical advantage in a higher interest rate environment.